Follow your curiosity

What discovery has been shared with you?

FACTREE gives you something interesting to discover every day — and something worth talking about together.

Start with one fact. Explore it, go deeper, then follow whichever branch catches your imagination.

Choose subjects for a surprise

Exploring any topic

Begin your discovery

Your next discovery is one click away.

Choose one or more subjects above, or leave Any Topic selected and let curiosity decide.

Medicine

Viral Reactivation Risk from JAK Inhibitors in Rheumatoid Arthritis

Quick fact

In clinical trials, the risk of herpes zoster (shingles) is roughly doubled with tofacitinib compared with placebo or TNF inhibitors, and the risk appears to increase with age and higher drug dose.

Why this is interesting

You might know that rheumatoid arthritis is treated by calming an overactive immune system. But what if the very drug that soothes your joints also switches on a dormant virus that most of us carry—and usually keep in check?